{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:26:58Z","timestamp":1776522418954,"version":"3.51.2"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Monitoring immunosuppressant levels, such as mycophenolic acid (MPA), cyclosporin A (CsA), and tacrolimus (TAC), in peripheral blood mononuclear cells (PBMCs) could be useful in organ transplant patients administered individualized therapy. The authors developed a liquid chromatography-tandem mass spectrometry assay technique to simultaneously determine immunosuppressant levels in PBMCs and assess their pharmacokinetics in Chinese renal allograft recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PBMCs were isolated from the whole blood of 27 Chinese renal transplant patients using Ficoll-Paque Plus solution, and cell number was determined; acetonitrile treatment for protein precipitation, and gradient elution was performed on an Agilent Eclipse XDB-C18 column (3.5 \u03bcm, 2.1 \u00d7 100 mm) with mobile phase: water and methanol (containing 2 mM ammonium formate); flow rate: 0.3 mL\u00b7min<jats:sup>\u22121<\/jats:sup>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The calibration curves of MPA, CsA, and TAC had a linear range (ng\u00b7mL<jats:sup>\u22121<\/jats:sup>): 0.098\u201339.2 (r = 0.9987), 0.255\u2013102 (r = 0.9969), and 0.028\u201311.2 (r = 0.9993), respectively. The extraction effects, matrix effects, and mean relative recovery of these immunosuppressants were 70.4%\u201393.2%, 72.7%\u201396.5%, and 90.1%\u2013112.4%, respectively. The within-day and between-day coefficients of variation were &lt;15%. The AUC<jats:sub>0\u201312<\/jats:sub> of MPA in PBMCs correlated well with those in plasma. The level of MPA, CsA, and TAC in PBMCs might be more stable during dosing interval.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The derived liquid chromatography-tandem mass spectrometry assay is suitable for simultaneously monitoring different immunosuppressants in PBMCs. Pharmacokinetic of MPA, CsA, and TAC displayed considerable interindividual variability. Intracellular monitoring of immunosuppressants may facilitate individualized therapy for renal allograft recipients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000765","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T14:44:02Z","timestamp":1598625842000},"page":"686-694","source":"Crossref","is-referenced-by-count":10,"title":["Establishment of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Immunosuppressant Levels in the Peripheral Blood Mononuclear Cells of Chinese Renal Transplant Recipients"],"prefix":"10.1097","volume":"42","author":[{"given":"Bing","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Ruijin Hospital, Jiaotong University School of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Qian","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ruijin Hospital, Jiaotong University School of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Shao","sequence":"additional","affiliation":[{"name":"Center of Organ Transplantation, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hui","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ruijin Hospital, Jiaotong University School of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Min","family":"An","sequence":"additional","affiliation":[{"name":"Center of Organ Transplantation, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Qiang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ruijin Hospital, Jiaotong University School of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Jun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Center of Organ Transplantation, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230928","first-page":"549","article-title":"An overview of transplant immunosuppression--history, principles, and current practices in kidney transplantation","volume":"41","author":"Colaneri","year":"2014","journal-title":"Nephrol Nurs J."},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.cca.2011.09.041","article-title":"Calcineurin inhibitors and NFAT-regulated gene expression","volume":"413","author":"Sommerer","year":"2012","journal-title":"Clin Chim Acta."},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","article-title":"Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update","volume":"88","author":"Staatz","year":"2014","journal-title":"Arch Toxicol."},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/FTD.0000000000000616","article-title":"Pharmacodynamic monitoring of mTOR inhibitors","volume":"41","author":"Mill\u00e1n","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/dta.2290","article-title":"Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs","volume":"10","author":"Zhang","year":"2018","journal-title":"Drug Test Anal."},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41401-018-0070-2","article-title":"Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation","volume":"40","author":"Fu","year":"2019","journal-title":"Acta Pharmacol Sin."},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00007691-200208000-00003","article-title":"Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month","volume":"24","author":"Morris","year":"2002","journal-title":"Ther Drug Monit."},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/17425255.2017.1395413","article-title":"Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients","volume":"13","author":"Andrews","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0012.2000.140201.x","article-title":"Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity","volume":"14","author":"Kahari","year":"2000","journal-title":"Clin Transpl."},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/clinchem\/47.1.88","article-title":"Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil","volume":"47","author":"Mourad","year":"2001","journal-title":"Clin Chem."},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinchem\/47.7.1241","article-title":"Pharmacokinetic basis of efficient and safe use of low mycophenolate mofetil (MMF, 1g\/day) in combination with tacrolimus in kidney transplant patients","volume":"47","author":"Mourad","year":"2001","journal-title":"Clin Chem."},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/TP.0b013e3181744199","article-title":"Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review","volume":"85","author":"Knight","year":"2008","journal-title":"Transplantation."},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/FTD.0000000000000392","article-title":"Simultaneous determination of protein-unbound cyclosporine A and mycophenolic acid in kidney transplant patients using liquid chromatography-tandem mass spectrometry","volume":"39","author":"Bittersohl","year":"2017","journal-title":"Ther Drug Monit."},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/FTD.0000000000000351","article-title":"Development of a simple and rapid method to measure the free fraction of tacrolimus in plasma using ultrafiltration and LC-MS\/MS","volume":"38","author":"Stienstra","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/FTD.0b013e3181f01397","article-title":"Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients","volume":"32","author":"Chen","year":"2010","journal-title":"Ther Drug Monit."},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FTD.0000000000000223","article-title":"Therapeutic drug monitoring of mycophenolic acid in lupus nephritis: a review of current literature","volume":"37","author":"\u0141uszczy\u0144ska","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/14656566.2015.1056734","article-title":"Advances in pharmacotherapy to treat kidney transplant rejection","volume":"16","author":"Bamoulid","year":"2015","journal-title":"Expert Opin Pharmacother."},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015011421","article-title":"Current state of immunosuppression: past, present, and future","volume":"25","author":"Karam","year":"2015","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am J Transpl."},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/TP.0b013e31815feede","article-title":"Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients","volume":"85","author":"Falck","year":"2008","journal-title":"Transplantation."},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(79)90268-0","article-title":"Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium","volume":"30","author":"Ulmer","year":"1979","journal-title":"J Immunol Methods."},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jpba.2018.01.002","article-title":"UPLC-MS\/MS assay validation for tacrolimus quantitative determination in peripheral blood T CD4+ and B CD19+ lymphocytes","volume":"152","author":"Romano","year":"2018","journal-title":"J Pharm Biomed Anal."},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","article-title":"Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study","volume":"25","author":"Capron","year":"2012","journal-title":"Transpl Int."},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bcp.13704","article-title":"Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients","volume":"84","author":"Md Dom","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchromb.2007.07.001","article-title":"Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach","volume":"857","author":"Ansermot","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R27-20230928","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2047-1440-2-5","article-title":"Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients","volume":"2","author":"Robertsen","year":"2013","journal-title":"Transpl Res."},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.clinbiochem.2013.02.011","article-title":"Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients","volume":"46","author":"Lemaitre","year":"2013","journal-title":"Clin Biochem."},{"key":"R29-20230928","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jpba.2015.01.054","article-title":"An UPLC-MS\/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells","volume":"107","author":"Pensi","year":"2015","journal-title":"J Pharm Biomed Anal."},{"key":"R30-20230928","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/bmc.3423","article-title":"Sensitive and validated LC-MS\/MS methods to evaluate mycophenolic acid pharmacokinetics and pharmacodynamics in hematopoietic stem cell transplant patients","volume":"29","author":"Kawanishi","year":"2015","journal-title":"Biomed Chromatogr."},{"key":"R31-20230928","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.clinbiochem.2013.09.009","article-title":"Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry","volume":"46","author":"Nguyen Thi","year":"2013","journal-title":"Clin Biochem."},{"key":"R32-20230928","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-2697(90)90032-5","article-title":"Spectrophotometric quantitation of anchorage-dependent cell numbers using the bicinchoninic acid protein assay reagent","volume":"184","author":"Tuszynski","year":"1990","journal-title":"Anal Biochem."},{"key":"R33-20230928","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jchromb.2007.01.039","article-title":"Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry","volume":"852","author":"Falck","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R34-20230928","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/FTD.0b013e31819c3f3d","article-title":"Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells","volume":"31","author":"Glander","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R35-20230928","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.phrs.2016.07.027","article-title":"Intra-cellular immunosuppressive drugs monitoring: a step forward towards better therapeutic efficacy after organ transplantation?","volume":"111","author":"Capron","year":"2016","journal-title":"Pharmacol Res."},{"key":"R36-20230928","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/bio.2015.0104","article-title":"Comparison of three isolation techniques for human peripheral blood mononuclear cells: cell recovery and viability, population composition, and cell functionality","volume":"14","author":"Grievink","year":"2016","journal-title":"Biopreserv Biobank."},{"key":"R37-20230928","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/FTD.0b013e3181905aaa","article-title":"Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells","volume":"31","author":"Capron","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R38-20230928","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3109\/00498250903226025","article-title":"Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients","volume":"39","author":"Chen","year":"2009","journal-title":"Xenobiotica."},{"key":"R39-20230928","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/jcpt.12599","article-title":"Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients","volume":"42","author":"Chen","year":"2017","journal-title":"J Clin Pharm Ther."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:05:43Z","timestamp":1695863143000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000765","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}